BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/10/2023 2:29:45 PM | Browse: 487 | Download: 1535
 |
Received |
|
2023-04-26 07:48 |
|
Peer-Review Started |
|
2023-04-26 07:50 |
|
First Decision by Editorial Office Director |
|
2023-06-15 01:04 |
|
Return for Revision |
|
2023-06-15 01:04 |
|
Revised |
|
2023-06-16 05:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-07-17 02:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-17 22:33 |
|
Articles in Press |
|
2023-07-17 22:33 |
|
Edit the Manuscript by Language Editor |
|
2023-07-10 15:30 |
|
Typeset the Manuscript |
|
2023-07-27 05:51 |
|
Publish the Manuscript Online |
|
2023-08-10 14:08 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through microRNA-370/PIM1 axis-regulated glycolysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-Ping Pan, Bu-Ren Jiya, Feng Wang and Zhu Lan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81960782 |
|
| Corresponding Author |
Xiao-Ping Pan, MD, Doctor, Doctor, Department of Interventional Radiology, Inner Mongolia International Mongolian Hospital, No. 83 University East Street, Hohhot 016000, Inner Mongolia Autonomous Region, China. xiongmi7122504@163.com |
| Key Words |
Hepatocellular carcinoma; Sorafenib resistance; Physcion; Glycolysis; PIM1 |
| Core Tip |
This study investigated the effects of physcion on sorafenib-resistance of hepatocellular carcinoma (HCC) cells. Through utilizing the in vitro and in vivo model, we determined that physcion could significantly enhance the anti-tumor effects of sorafenib on sorafenib-resistant HCC cells, inducing apoptosis and suppressing cell growth. Further exploration on mechanisms identified that physcion repressing HCC cells glycolysis via targeting the microRNA-370/PIM1 axis, which consequently sensitized HCC cells to sorafenib. |
| Publish Date |
2023-08-10 14:08 |
| Citation |
Pan XP, Jiya BR, Wang F, Lan Z. Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through microRNA-370/PIM1 axis-regulated glycolysis. World J Gastrointest Oncol 2023; 15(8): 1400-1411
|
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i8/1400.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i8.1400 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
